World's First Honey Bee Vaccine Seeks to Save Dying Pollinators
(Bloomberg) -- A growing number of honey bees die each year due to pesticides, vanishing habitats, poor nutrition and climate change, with potentially disastrous consequences for agriculture and natural diversity.
Now, scientists at the University of Helsinki have developed the first edible vaccine against microbial infections, hoping to save at least some of the pollinators.
“We might be right now at a tipping point, without even realizing it,” Dalial Freitak, the lead scientist on the project, said in an interview on Wednesday. “We've been taking the pollination services for granted for so long. These insects are not there, they are disappearing.”
The first vaccine inoculates bees against American foulbrood, a globally spread disease that can kill entire colonies and whose spores can remain viable for more than 50 years. The technology may in future be used to combat fungal diseases and other bacterial infections.
Read more on the bee blight in a QuickTake explainer
The vaccine is administered via an edible sugar patty that's suspended in the hive for the queen to consume over seven to 10 days. After she ingests the pathogens, she is able to spark an immune response in her offspring, eventually generating an inoculated hive.
The vaccine still needs a lot of work before it can become commercially available. Scientists must ensure it's safe for the environment, the bees themselves and humans who consume the honey. Regulatory hurdles will take years to clear. It's also too early to estimate how much beekeepers will have to shell out to buy inoculated hives, Freitak said.
While yields for potatoes, rice, wheat, and other crops that don't need pollination may also benefit from more bees, vitamin-rich fruits such as apples, tomatoes and citruses won't deliver a crop without them, Freitak said.
“The problem really touches all of us,” she said. “We have to start tackling it from all sides.”
To contact the reporter on this story: Kati Pohjanpalo in Helsinki at kpohjanpalo@bloomberg.net
To contact the editors responsible for this story: Tasneem Hanfi Brögger at tbrogger@bloomberg.net, Nick Rigillo
©2018 Bloomberg L.P.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.